SearchIP Handbook Blog
Your source for expert commentary on IP management issues. About |
Home > Author Index > SODERSTROM, Jon SODERSTROM, Jon
Prior to holding this position, Dr. Soderstrom was the Director of Program Development for Oak Ridge National Laboratory (ORNL); previously, he had served for ten years as Director of Technology Licensing for Martin Marietta Energy Systems. In the Office of Technology Transfer, he directed a group of ten professionals responsible for negotiating licenses and Cooperative Research and Development Agreements (CRADAs). Dr. Soderstrom was a founding board member and past president of the Association of Federal Technology Transfer Executives. He is also a member of the Licensing Executive Society and the Association of University Technology Managers (AUTM). He is the President-Elect of AUTM, has served as Vice President for Public Policy, and is a member of the Board of Directors and Executive Committee. He is frequently asked to lecture and teach seminars on various aspects of the technology transfer process and economic development both within the United States and abroad. He has testified before Congress on technology transfer issues and served as an expert witness in patent infringement litigation. In addition to his professional accomplishments, Dr. Soderstrom was honored as the 87th “Point of Light” by President George H. W. Bush in March of 1990 for his volunteer work in constructing and rehabilitating low-income housing in East Tennessee. Dr. Soderstrom received his Ph.D. from Northwestern University in 1980 and his A.B. from Hope College in 1976.
Contributions
|
Get the printed IP Handbook or its Executive Guide.
|
Printer Friendly
Jon Soderstrom is currently the Managing Director of the Office of Cooperative Research at Yale University. The Office manages the intellectual assets created at Yale in order to achieve the maximum benefit for the public and provide a financial return that will support the university’s research efforts. He is responsible for (1) developing and managing the intellectual property portfolio, (2) defining and executing commercialization strategies, including the negotiation of licenses and corporate-sponsored research agreements, and (3) developing and marketing business concepts for new spin-off ventures to the investment community. Since joining the Office in 1996, he has participated in the formation of more than 25 new ventures, including polyGenomics, Molecular Staging (acquired by Qiagen), Agilix, Asilas Genomic Systems, Achillion Pharmaceuticals (NASQ: ACHN), PhytoCeutica, Protometrix (acquired by Invitrogen), Iconic Therapeutics, Applied Spine Technologies, HistoRx, and VaxInnate. Collectively, these companies have raised over $350 million in professional venture capital.
Show All Abstracts
Abstract